This essay has been submitted by a student. This is not an example of the work written by our professional essay writers.
Development of validated UV-Visible Spectroscopic, Spectrofluorimetric, HPLC and HPTLC methods for Certain Selected Drugs in Formulations and Biological Fluids.
As the technology is developing, a number of new drugs are launched in the market and it becomes necessary to develop newer analytical methods. It is necessary to do if, no analytical methods are available for a drug in official books, no literature reveals methods for the determination of drugs, analytical method available only for a single drug in combined dosage form and no methods reported for the estimation of drugs in biological fluids.
Quality control plays a vital role in determining safety and efficacy of drugs. Highly specific and sensitive analytical technique holds the key to the design, development, standardization and quality control of medicinal products. It is important that the analytical procedure proposed for a particular active ingredient or its dosage form should be systematically evaluated so as to demonstrate that the method is scientifically sound under the condition in which it is to be applied (1,2). Method validation is the process of documenting or proving that an analytical method provides analytical data acceptable for the intended use (3)
Chromatographic and spectroscopic methods are widely used instrumental techniques for the analysis of pharmaceuticals. HPLC is a versatile separation technique and is official in most of the Pharmacopoeias for determining content uniformity, purity profile, assay values and dissolution rates in unlimited number of monographs (4). It offers variety of stationary phases, which allows a great diversity of selective interactions and more possibilities for separation. Sample recovery is easy in HPLC (5). It is specific, highly sensitive, precise and readily adaptable to accurate quantitive determinations. RP-HPLC is more convenient, widely used for assay and impurity analysis for pharmaceutical quality control. It is rugged than other forms of liquid chromatographic techniques and more likely to result in a satisfactory final separation (6).
The International Conference on Harmonization (ICH) guideline entitled "Stability testing of New Drug Substances and Products" (Q1A) requires that stress testing be carried out to elucidate the inherent stability characteristics of the active substance(7).
HPTLC is the most simple separation technique available to the analyst. It is cost effective, environment friendly and less time consuming. Solvent consumption is less when compared to HPLC. Sample clean up is not required. Other advantages of HPTLC include simultaneous processing of sample and standards, better analytical precision and accuracy, and less need for internal standard. In this, no prior treatment for solvent like filtration and degassing are required. There is no interference from previous analysis since fresh stationary phase and mobile phase are used for each analysis. Sample applied in the form of bands results in better separation and significantly less matrix effects. A major advantage in HPTLC technique is that the standards, formulations and recovery samples can be run simultaneously (4).
Methods of measuring drugs in biological media are more important nowadays. Problems related to bioavailability and bioequivalence, new drug development, drug abuse, clinical pharmacokinetics and drug research are highly dependent on bio analytical methods (8)
The technique of derivative spectroscopy is useful in eliminating matrix interference in the assay of many medicinal substances. Hence, the specificity of detection is more in derivative spectroscopy. Generally, first and third derivatives are used to fix the accurate Î» max. The second and fourth order derivatives are widely used for quantitative determination. These spectra are sharper than original band but of the same height; its sign alternates with increasing order. It is clear that resolution is improved in the even-order spectra (9). For quantitative measurements, peak heights (measured in mm) of the long-wave peak (DL) satellite of second order derivative curve are usually measured. This technique is useful in the analysis of two or more components in a single formulation without prior separation and leads to better spectral isolation (10). Major advantages of second derivative spectroscopy include the possibility of recognizing absorption bands when two or more absorption bands are overlapping at the same wavelength or at slightly different wavelengths. The quantitative analysis becomes simpler in presence of background absorption since a linear relationship with good correlation can be drawn between the derivative value and the concentration (9).
The selectivity of spectrofluorimetric method is greater than absorption methods because both the emission and excitation spectra can be obtained as single spectrum. Luminescence measurements are more sensitive than absorption methods. In fluorescence method, concentration is directly related to fluorescence intensity, which can be measured at right angle to the incident radiation (5).
Several popular fixed dose combinations are available in Indian pharmaceutical market, which have flourished in the last few years. Fixed dose combinations have two or more drugs at a fixed ratio in a single dosage form. (11). NSAIDs such as aceclofenac and lornoxicam are commonly available in combination with antispasmodics like drotaverine, thiocolchicoside and analgesics like diacerein and paracetamol. Fenoverine and thiocolchicoside are novel antispasmodic drugs. An extensive literature review reveals that there are limited methods reported for the analysis of the above mentioned fixed dose combinations and fenoverine ,lornoxicam and thiocolchicoside in single dosage form. Further, drug displacement interaction studies also necessitate accurate and sensitive analytical techniques. Nebivolol and carvedilol are cardiovascular drugs used for treating hypertension and heart failure. NSAIDs like aceclofenac and lornoxicam are widely prescribed. NSAIDs are highly bound to plasma albumin and displace several concomitantly administered drugs. Literature reported that nebivolol and carvedilol are also highly bound to plasma albumin. But the effect of aceclofenac and lornoxicam on protein binding of nebivolol and carvedilol are not yet reported. Therefore, there is an unmet need to develop validated chromatographic, spectroscopic and bioanalytical methods for the assay of selected single and fixed dose combinations and for in-vitro drug displacement interactions.
Aim and Objectives:
An extensive literature review reveals that there are limited methods reported for the analysis of the above mentioned fixed dose combinations and in single dosage forms. The available bio analytical methods for fenoverine and aceclofenac are time consuming and involve more sophisticated instruments. Hence, it is in need for developing bio analytical methods for these drugs using HPTLC technique, now a day's which is more popular. Further, drug displacement interaction studies for the effect of aceclofenac and lornoxicam on protein binding of nebivolol and carvedilol are not yet reported.
Therefore, the aim of the present study is to develop validated chromatographic, spectroscopic and bio analytical methods for the assay of selected single and fixed dose combinations and in-vitro drug displacement interactions for nebivolol and carvedilol with aceclofenac and lornoxicam. The objective of the wok was as follows:
1.To develop validated spectroscopic and chromatographic methods for certain selected formulations ( formulation I- VIII)
Diacerein and aceclofenac (formulation I)
Drotaverine and aceclofenac (formulation II)
Paracetamol and lornoxicam (formulation III)
Thiocolchicoside and aceclofenac (formulation IV)
Thiocolchicoside and lornoxicam (formulation V)
Fenoverine (formulation VI)
Lornoxicam (formulation VII)
Thiocolchicoside (formulation VIII)
2. To develop validated bio-analytical methods using HPTLC technique for two selected drugs.
3.To develop validated RP-HPLC methods for nebivolol and carvedilol and its application to in vitro drug displacement interaction studies as follows:
Nebivolol with aceclofenac and lornoxicam
Carvedilol with aceclofenac and lornoxicam
Santosh et al (12) reported a validated HPTLC method for the determination of diacerein and aceclofenac in pharmaceutical dosageform by solid-liquid extraction method. Paracetamol was used as the internal standard. Ethyl acetate: methanol: glacial acetic acid in the ratio of (12: 0.5: 0.2 v/v/v) was used as the mobile phase.
Sarika et al (13) developed a simultaneous UV spectrophotometric method for the determination of diacerein and aceclofenac in tablets by simultaneous equation method. The selected wavelengths were 258 and 274 nm. Linearity was found to be 1-10 and 5-40 mcg/ml for diacerein and aceclofenac.
Gopal et al (14) reported a RP-HPLC method for the simultaneous determination of diacerein and aceclofenac in tablet dosage form using 0.01 M potassium dihydrogen phosphate and acetonitrile 60:40 (v/v) at 280 nm. The retention time was found to be 3.61 and 6.28 min, respectively. RSD was less than 2%.
Vivek et al (15) developed three different UV spectroscopic methods for the simultaneous estimation of drotaverin and aceclofenac in combined dosage form. The method involved solving simultaneous equation, absorbance ratio method and First Order Derivative Spectroscopy. Linearity was found to be 10-50 for both the drugs.
Vishnu et al (16) proposed a RP-HPLC method with PDA detector for the simultaneous determination of drotaverine HCl and aceclofenac in tablet dosage form. Methanol: tetrahydrofuran: acetate buffer (68:12:20 v/v) at a flow rate of 1.0 mL min-1 was used to achieve separation. Temperature of the column was maintained at 50 Â°C. Linearity was found to be in the range of 1 - 150 and 1.25 - 187.5 Î¼g mL-1 for Drotaverine HCl and Aceclofenac respectively.
Bhavsar et al (17) reported a spectrophotometric method for the simultaneous estimation of paracetamol and lornoxicam by solving simultaneous equation using 0.1 N NaOH as solvent. Linearity was found to be 5-30 and 2-10 mcg/ml at 257 and 287 nm for paracetamol and lornoxicam, respectively.
Kiran et al (18) demonstrated a stability indicating RP-HPLC method for lornoxicam in its dosage form. The separation was achieved in presence of degradation products using 0.05%trifluoroacetic acid with acetonitrile in the ratio of 70:30 at 295 nm.
Venumadhav et al (19) established two colorimetric methods for the estimation of lornoxicam in bulk and dosage form using ferric chloride in presence of 2,2' bipyridine and bathophenanthroline. The linearity was found to be in the range of 3-20 and 2-10 Âµg/ml.
Arvind et al (20) reported a stability indicating RP -HPLC method for the estimation of thiocolchicoside in capsules. Separation was achieved using C18 column (250mm Ã- 4mm, 5Î¼m) with a mobile phase composed of acetonitrile: water (70:30) at a flow rate was 1.0 mL min-1 . Linearity was established in the range of 0-10Î¼g/ml and correlation coefficient as 0.9996.
Sasmita et al (21) reported four different UV spectrophotometric methods for the determination of thiocolchicoside in formulations. All methods obeyed beer's law concentration in the range of 2.5-50 Î¼g/ml
Sohan et al (22) developed spectrophotometric and Chromatographic method for the simultaneous estimation of thiocolchicoside and aceclofenac in fixed dose combination. Linearity was found to be 4-36 Î¼g/ml for thiocolchicoside and aceclofenac using spectrophotometric technique. Acetonitrile: water: 0.025M pot.dihydrogen orthophosphate buffer in the ratio of 70:10:20 % v/v/v was used as mobile phase for HPLC method. pH was adjusted to 3 using orthophosphoric acid
Shekhar et al (23) reported a RP-HPLC technique the simultaneous estimation of lornoxicam and thiocolchicoside from tablets. Resolution was obtained using a Phosphate buffer and methanol in the ratio of 45:55at a flow rate of 1.5ml/min. Detection was carried out at 290 nm.
Hu OY et al (24) reported the determination of fenoveine in capsules and plasma by RP-HPLC method. A Nucleosil 5-micron CN column was used as the stationary phase. Mobile phase composed of acetonitrile:0.1 M ammonium acetate (60:40) was used as the mobile phase and detection was performed at 254 nm. Linearity was established in the range of 24.6 to 147.6 mcg/ml of fenoverine.
Suresh et al (25) reported HPLCmethod with UV detection for the estimation of fenoverine in human serum. The extracting solvent used was dichloromethane and chlorpromazine hydrochloride was used as internal standard (I.S). Acetonitrile, water, and 0.375% v/v triethylamine ( 41:59Â v/v) at a flow rate of 1Â mLÂ min-1 was employed to achieve the separation. The method was linear in the range of 5 to 2000Â ngÂ mL-1.
Sahoo et al (26) proposed RP-HPLC method for the estimation of nebivolol in tablet dosage form using Hypersil ODS C18 column as stationary phase and methanol-water in the ratio of 80:20 as mobile phase. Detection was carried out at 282 nm. The linearity was found between 1-400 gm/ml using the internal standard chlorzoxazone. LOD was found to be 0.0779 gm/ml.
Patel et al (27) developed two simple chromatographic techniques for the determination of carvedilol. The stationary phase and mobile phase used in RP-HPLC method were Lichrospher 100 C-18, 5 Âµm column consisting of 200Ã-4.6 mm and 50 mM KHÂ 2Â POÂ 4Â buffer (pH 3.0Â±0.1): acetonitrile: methanol (60:50:10 v/v/v) at a flow rate of 1ml/min. In HPTLC, precoated silica gel 60FÂ 254Â and ethyl acetate: toluene: methanol (1:4:3.5 v/v/v) were used for the separation. The linearity was found to be 1-35 Âµg/ml for HPLC and 50-300 ng/spot for HPTLC.
Ashraful et al (28) employed equilibrium dialysis method for the in-vitro displacement interaction study of amlodipine and arseinic to bovine serum albumin. Free concentration of amlodipine was determined spectrophotometrically at a wavelength of 238 nm. It was found that amlodipine was slowly displaced from its binding site by arsenic.
Mohiuddin et al (29) demonstrated in-vitro displacement interaction of gliclazide and metformin with caffeine by equilibrium dialysis method. Unbound concentrations were measured using UV spectrophotometer at 273nm. It was reported that both gliclazide and metformine displaces caffeine from its binding site, resulting in increase in the free concentration of caffeine in plasma.
Materials and Methods
HPLC methods were developed for simultaneous estimation of five different formulations (formulation I-V) and a single dosage forms (formulation VI). Since all the selected analytes are polar in nature, RP-HPLC technique was employed. Prepacked RP-18 column (250Ã-4.6 mm, 5 Âµm particle size) and HPLC - Cartridge RP-18 column (250Ã-4 mm, 5 Âµm particle size) were used as the stationary phase. RP-18 columns are generally efficient, stable and reproducible because of the solvents used. Organic phase was selected on the basis of retention time and shape of the peak obtained. Mobile phase was selected on the basis of solubility and stability of the analytes. For improved separation, different solvent strength, solvent type, solvent composition and varying pH were tried. The ratio of the mobile phase was chosen in order to get acceptable k values and retention time.
Water: acetonitrile (45: 55, v/v) was used as the mobile phase for formulation I. For formulation II and IV, 0.1%trifloro acetic acid:acetonitrile (45:55,v/v) was used. Methanol: 10mM ammonium acetate in the ratio of 50:50, v/v was used for formulation III and V. In the case of formulation VI, methanol, acetonitrile and 10mM ammonium formate (70:10:20, v/v/v) was used.
Forced degradation studies were conducted under different stress conditions like hydrolysis, oxidation, dry heat and photolysis. Dry heat and photolytic degradation of drug product were carried out in solid state. For each study, four samples were prepared: the blank solution stored under normal condition, the blank subjected to stress in the same manner as the drug solution, zero time sample containing the drug which was stored under normal conditions and the drug solution subjected to stress treatment.
HPTLC methods were developed for simultaneous estimation of five selected combinations (formulation I-V). A Camag high performance thin layer chromatography system comprising of Linnomat V automatic sample applicator, Hamilton Syringe, Camag TLC Scanner-3, Camag Win CAT software with stationary phase precoated silica gel 60FÂ 254 were used. Chemical properties of analytes and the sorbent layer were taken into consideration while fixing the mobile phase. Mobile phase was selected by controlled process of trial and error. Mobile phase containing n- hexane- ethyl acetate-dioxane-ammonia, (5.0: 2.2: 1.8:0.02v/v/v) was used in formulation I. A mixture of methanol-ethyl acetate-glacial acetic acid in the ratio of 1:9:0.01v/v/v and 2:8:0.01v/v/v were used as the mobile phase for formulation II and IV. Toluene, n-propanol and ammonia (7:3:0.2) was used for formulation III while Toluene: ethanol: ammonia (6:4:0.1) was the suitable mobile phase for formulation V. The classical method of linear ascending development in a mobile phase vapor-saturated, covered twin trough chamber was used for the development. The separated compounds were detected under UV light. Densitometric quantitative analysis was done by UV scanning of fluorescence-quenched zones in the absorbance-reflectance mode. In the present study, external standardization was used for quantification with a calibration curve generated from a series of standards covering the full concentration range of analysis.
Derivative spectroscopic technique is useful in analysis of two or more components in a single formulation without prior separation and leads to better spectral isolation. Here normal spectra were converted to second order derivative spectra. For establishing the optimum parameters for the estimation of formulation I - IV, suitable concentrations of standard stock solutions were prepared using methanol. Absorption maximum and Beer's law concentration at Î» max of selected drugs were established. Linear graph of second derivative spectra was prepared using the long-wave peak (DL) height covering the wavelength range Â±1nm of individual Î» max of each drug selected versus concentration of the corresponding drug. By comparison with the calibration plots of individual components, the concentrations of unknown drugs were deduced. The